Many air quality challenges are unique to specific settings. We can use the latest technologies to evaluate indoor air quality challenges, and work confidentially with clients to provide prescribe the best custom mobile or infrastructure-based solution.
Copyright 2016 Aerobiotix, Inc.
NOTE: Products not marketed for prevention or treatment of disease.
At Aerobiotix, we are clean air experts. We have placed state of the art air treatment systems into hospitals, businesses, and homes worldwide. These systems use advanced and proprietary methods to eliminate airborne viruses, spores, bacteria, VOCs and particulates. Our technology includes advanced ultraviolet reactors, which use patented air-sink technology to safely maximize UV dosage, photochemical oxidation using unique zirconium-based catalysis, and cleanroom-grade true HEPA filtration, and real-time laser air particulate monitoring.
For our residential air purification products please go to Aerocure.com
For our central HVAC products, please go to Ultravair.com
The latest in in-room recirculation-purification-disinfection technologies combining high flow of 500 CFM with reduced footprint, variable output, and real-time air particulate monitoring. COMING SOON
Our original validated high flow recirculating portable air disinfection and purification system, trusted globally in operating rooms, central supply areas, and construction areas to reduce particulate and bioaerosol bioburden.
Our Mission is to design and manufacture the very best, highest-quality air purification technologies to improve health, and build better indoor environments globally. - Because individuals everywhere deserve the right to breathe clean, healthy air. Aerobiotix Inc. was conceived around one central idea: Creating healthier environments through proprietary active air management strategies. Our first objective was to target air quality inside the hospital operating room. Our first product, Tower One (T1) was created to fulfill this need. The T1 is the ultimate air purification and disinfection system - the first of its kind. Today, our technologies benefit people around the globe as we have expanded into residential and commercial markets.
350 Fame Road
West Carrollton, Ohio USA
+1 888 978 7087
Air samples were taken in two locations in an urban midwestern USA hospital setting. The location used was a 5 x 6m active general surgical operating room with standard positive-pressure ventilation. The sampling locations were immediately behind the sterile instrument table. Samples were taken with the C-UVC device in place, but turned off, and then repeated after 30 minutes of the C-UVC device running. In each test modality, air samples were taken every 60 seconds, until the detected particle levels reached a stable equilibrium. Samples were taken in two groups: operating room active baseline, operating room active after 30 minutes use of C-UVC unit.
The Aerobiotix system was independently tested and validated at the Center for Microbial Community Systems and Health Research at the Research Triangle Institute. RTI is fully accredited and recognized worldwide as a leader in the evaluation of aerobiological technologies and is a primary air unit testing contractor to the US government, including the EPA and biodefense agencies.
In a controlled laboratory setting, a single pass through the device, running at standard 450 cubic feet of air per minute, the Aerobiotix system inactivated:
The Aerobiotix Tower One (T1) system uses a novel and proprietary air disinfection technology to disinfect large amounts of room air with virtually complete eradication of bacteria, viruses, and spores.
The unit disinfects 450 cubic feet per minute of air,
circulating and sterilizing the air of a typical 20 x 20
room every 8 minutes.
It draws contaminated air from the base of unit and
expels cleaned high volume, low velocity air from the
top of the unit creating a continuous circulation
without disruptive air currents.
Objective. To evaluate the effectiveness of a novel in-room air disinfection technology through the use of real-time viable airborne particulate counting.
Methods. Using laser particle fluorescence techniques in real time, airborne viable particle concentrations were obtained before and after air treatment with the in-room C-UVC device (Aerobiotix Tower One) in an active hospital operating room setting.
Results. A large number of viable airborne particles were found in the active positive-pressure operating room setting, with an average of 18628 viable particles per cubic meter in the 1.0-10.0 um diameter range. Thirty minutes after activation of the C-UVC device, the number was reduced to 914 viable particles per cubic meter in the same size range. Reductions were consistent across the particle sizes.
Conclusion. The C-UVC device, when employed as an in-room recirculation unit, provides significant reduction in airborne viable particle levels in a hospital environmental setting. The use of laser fluorescence-based techniques to track airborne viable particulate counts is a valuable tool for the rapid assessment of airborne bioload and the evaluation of air germicidal technologies.